|
Session 100
Poster Abstracts
Prevention, Identification and Treatment of at-Risk and HIV-infected Adolescents
Tuesday, 1-4 pm
Room: Hall A |
602
 |
Comparison of the Current Health Status and Selected Baseline Characteristics of Perinatally and Behaviorally HIV-infected Children and Adolescents, through 24 Years of Age in the US: The CDC LEGACY Cohort Study, 2006 to 2007
Kenneth Dominguez*1, B Bohannon1, J Milum2, and The CDC LEGACY Consortium
1CDC, Atlanta, GA, US and 2Ginn Group Inc, Atlanta, GA, US |
603
|
Discordance in HAART Utilization Rates in HIV-1-infected Adolescents in a Multi-site US Cohort
Allison Agwu*1, J Ellen1, R Rutstein2, A Gaur3, S Spector4, R Warford5, G Siberry1, K Gebo1, and for the HIV Research Network
1Johns Hopkins Univ, Baltimore, MD, US; 2Children`s Hosp of Philadelphia, PA, US; 3St Jude Children`s Res Hosp, Memphis, TN, US; 4Univ of California, San Diego, US; and 5St Luke`s Roosevelt Hosp, New York, NY, US |
604
|
Directly Observed Therapy for Non-adherent HIV-infected Adolescents--Lessons Learned, Challenges Ahead
Aditya Gaur*1, M Belzer2, P Britto3, P Garvie1, C Hu3, B Graham4, K Klingman5, M Neely6, G McSherry7, and P Flynn1
1St Jude Children`s Res Hosp, Memphis, TN, US; 2Children`s Hosp Los Angeles, CA, US; 3Harvard Sch of Publ Hlth, Boston, MA, US; 4Frontier Sci and Tech Res Fndn, Amherst, NY, US; 5Div of AIDS, NIAID, NIH, Bethesda, MD, US; 6Univ of Southern California, Los Angeles, US; and 7Univ of Med and Dentistry of New Jersey, Newark, US |
605
|
Poor Virologic Control in Pregnant Adolescents with Perinatally Acquired HIV Infection as Compared to Horizontally Infected Pregnant Women
Usha Phillips*1, J Sansary2, M Rosenberg2, J Dobroszycki2, M Katz2, A Wiznia2, and J Abadi2
1Montefiore Med Ctr, Albert Einstein Coll of Med, Bronx, NY, US and 2Jacobi Med Ctr, Albert Einstein Coll of Med, Bronx, NY, US |
606
|
Risk Factors for HIV Infection among Sexually Active Adolescents and Youth Seeking Voluntary Counseling and Testing in Haiti
Tsogzolmaa Dorjgochoo*1, F Noel2,3, M Deschamps2,3, H Theodore2,3, W Dupont1, P Wright1,3, D Fitzgerald2,3, S Vermund1, and J Pape2,3
1Vanderbilt Univ Sch of Med, Nashville, TN, US; 2Weill Med Coll of Cornell Univ, New York, NY, US; and 3GHESKIO, Port-au-Prince, Haiti |
607
|
Preparing for Adolescent HIV Vaccine Trials: Will Adolescent Participants Experience Social Harms?
Daniella Mark*1, H Jaspan1,2, E Ryan Burrell1, P Mthimunye1, K Middelkoop1, N Soka1, R Wood1, and L G Bekker1
1Desmond Tutu HIV Ctr, Inst of Infectious Disease and Molecular Med, Univ of Cape Town, South Africa and 2Tygerberg Hosp, Cape Town, South Africa |
|
